How PARP inhibitors (PARPi) work

(3:12)

PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023

(59:14)

Gynecologic Cancer Education: PARP Inhibitor Therapy

(24:56)

An Overview of PARP Inhibitors in Ovarian Cancer

(3:5)

The Role of Targeting DNA Repair with PARP

(12:24)

PARP Inhibitors for Maintenance Therapy in Ovarian Cancer

(1:26)

PARP Inhibitors for Prostate Cancer

(1:43)

PARP inhibitors – a cancer drug discovery story | Professor Ruth Plummer FMedSci

(12:11)

PARP inhibitors for ovarian cancer

(3:45)

Seminar Clips: PARP Inhibitors and BRRCA1/2 Cancers- Susan Domchek, MD | Stanford Cancer Institute

(2:38)

PARP Inhibitor Side Effect Management in Ovarian Cancer

(6:35)

PARP Inhibition Improves Outcomes in Patients With BRCA-Mutated Ovarian Cancer

(1:27)

What’s New with PARP Inhibitors and Ovarian Cancer?

(58:44)

Overcoming resistance to PARP inhibition in ovarian cancer

(1:22)

Choosing the correct PARP inhibitor for prostate cancer

(1:1econd)

Adverse-Effect Profiles of PARP Inhibitors in Ovarian Cancer

(5:53)

Do I Need PARP Inhibitors To Treat My Breast Cancer? What to Expect, Eligibility, and Side Effects

(6:22)

Updates in PARP inhibition for ovarian cancer

(1:38)

Where can PARP inhibitors be used

(1:2)